Logo image of DDD.CA

METAVISTA 3D INC (DDD.CA) Stock Fundamental Analysis

TSX-V:DDD - TSX Venture Exchange - CA59142H1073 - Common Stock - Currency: CAD

1.6  -0.07 (-4.19%)

Fundamental Rating

1

Overall DDD gets a fundamental rating of 1 out of 10. We evaluated DDD against 15 industry peers in the Electronic Equipment, Instruments & Components industry. DDD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DDD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DDD had negative earnings in the past year.
DDD.CA Yearly Net Income VS EBIT VS OCF VS FCFDDD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 20K -20K 40K -40K 60K -60K

1.2 Ratios

DDD's Return On Assets of -60.03% is on the low side compared to the rest of the industry. DDD is outperformed by 73.33% of its industry peers.
Looking at the Return On Equity, with a value of -107.01%, DDD is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
ROA -60.03%
ROE -107.01%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DDD.CA Yearly ROA, ROE, ROICDDD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 100 -100

1.3 Margins

DDD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DDD.CA Yearly Profit, Operating, Gross MarginsDDD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for DDD remains at a similar level compared to 1 year ago.
DDD has about the same debt/assets ratio as last year.
DDD.CA Yearly Shares OutstandingDDD.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 20M 40M 60M 80M 100M
DDD.CA Yearly Total Debt VS Total AssetsDDD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20K 40K 60K 80K 100K

2.2 Solvency

An Altman-Z score of 641.61 indicates that DDD is not in any danger for bankruptcy at the moment.
DDD has a Altman-Z score of 641.61. This is amongst the best in the industry. DDD outperforms 100.00% of its industry peers.
DDD has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
DDD has a Debt to Equity ratio (0.17) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 641.61
ROIC/WACCN/A
WACCN/A
DDD.CA Yearly LT Debt VS Equity VS FCFDDD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 50K -50K

2.3 Liquidity

A Current Ratio of 2.28 indicates that DDD has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.28, DDD is doing good in the industry, outperforming 66.67% of the companies in the same industry.
DDD has a Quick Ratio of 2.28. This indicates that DDD is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.28, DDD is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.28
DDD.CA Yearly Current Assets VS Current LiabilitesDDD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 50K 100K

More info and screens

0

3. Growth

3.1 Past

DDD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DDD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DDD.CA Price Earnings VS Forward Price EarningsDDD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DDD.CA Per share dataDDD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DDD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

METAVISTA 3D INC

TSX-V:DDD (6/2/2025, 7:00:00 PM)

1.6

-0.07 (-4.19%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap182.10M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 840.31
P/tB 840.31
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.03%
ROE -107.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.28
Altman-Z 641.61
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-213.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1412%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1412%
OCF growth 3YN/A
OCF growth 5YN/A